Theriva Biologics Inc (TOVX)

[Sagacious]

What the future holds for SYN
Lets lay out all of the catalysts from now until Q1 of 2016. We got two phase 2a trials for SYN-004, phase 2a-1 trial results in September, phase 2a-2 results in December.

We have two phase 2 trials for SYN-010, phase 2-1 trial results in September, phase 2-2 results in December. Then my guess is fast track/QIDP status will be granted to SYN-004 if both phase 2a trials are positive. FDA is very desperate for a C-diff preventative or treatment (if I were them, I'd rather have the preventative), so they want to get SYN-004 to market as fast as possible. And we will also be getting SYN-004 phase 2b interim results in December.

My guess is we will get a Trimesta partner by end of 2015, as Liz and many others have mentioned, there is no timeline. No clue as to when we get the MRI data. But go look at post #975 written by Liz, and that will give you a good idea of what the MRI data will show.

We should also get an update on the P2A drug, which is currently being tested in a pig microbiome. Between all of those catalysts, I bet our pps will be somewhere in the 8-12 range. I don't think we will have to raise until at least Q2 of 2016, maybe later depending on the amount of funding from the Trimesta partner. The future for SYN is very bright, and if they have to dilute, so what? They are a small cap bios, get over it. All small cap bios have to dilute every now and then. As long as XON keeps taking shares as payment for the PKU, that is all I need to know to keep me invested. Here's to a good Fall and Winter for SYN, and I personally believe SYN will become one of the largest cap biotechs in the market over the next 15-20 years if they don't get gobbled up by a big pharma, you just have to be patient. Do your own DD, and don't let the bashers get to you. GLTAL